Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi®
Clinical trial NCT07663526 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07663526
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.